Literature DB >> 15350044

Giant cell tumor of the sacrum.

R Lor Randall1.   

Abstract

Giant cell tumor (GCT) is a locally highly aggressive tumor of bone comprising 5 to 10% of all benign bone tumors. The sacrum is the third most common site of involvement. Patients with sacral GCTs present with localized pain in the lower back that may radiate to one or both lower limbs. Vague abdominal complaints and bowel and bladder symptoms may also be present. Neuroimaging workup should include advanced modalities, preferably magnetic resonance imaging, prior to obtaining a biopsy specimen. Giant cell tumor has a 1 to 5% rate of metastasizing to the lung and may convert to a fulminate malignant variant, which has a very poor prognosis. The standard treatment for GCT is curettage combined with adjuvant bone grafting or cement-augmented stabilization. In appropriately selected cases, sacral resection is a valuable procedure to effect local tumor control and overall survival. Embolization may also prove palliative and/or curative in cases in which the tumor is unresectable or refractory to treatment.

Entities:  

Mesh:

Year:  2003        PMID: 15350044     DOI: 10.3171/foc.2003.15.2.13

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  13 in total

Review 1.  Imaging of presacral masses--a multidisciplinary approach.

Authors:  Nishant Patel; Katherine E Maturen; Ravi K Kaza; Girish Gandikota; Mahmoud M Al-Hawary; Ashish P Wasnik
Journal:  Br J Radiol       Date:  2016-02-01       Impact factor: 3.039

2.  Bilateral Hydronephrosis Secondary to Giant Cell Tumor of the Sacrum.

Authors:  Omer Farooq Rehman; Amer K Hussain; Mohammad Ummair; Musab Umair; Muhammad Waqar
Journal:  Cureus       Date:  2020-12-15

Review 3.  Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature.

Authors:  Christopher Martin; Edward F McCarthy
Journal:  Iowa Orthop J       Date:  2010

4.  Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Giuseppe Ussia; Andrea Angelini; Panayiotis J Papagelopoulos; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

5.  Expression of IMP3 and IGF2 in giant cell tumor of spine is associated with tumor recurrence and angiogenesis.

Authors:  K Zhang; M Zhou; H Chen; G Wu; K Chen; H Yang
Journal:  Clin Transl Oncol       Date:  2015-03-05       Impact factor: 3.405

6.  Disappearance of giant cells and presence of newly formed bone in the pulmonary metastasis of a sacral giant-cell tumor following denosumab treatment: A case report.

Authors:  Tetsuro Yamagishi; Hiroyuki Kawashima; Akira Ogose; Taro Sasaki; Tetsuo Hotta; Shoichi Inagawa; Hajime Umezu; Naoto Endo
Journal:  Oncol Lett       Date:  2015-11-04       Impact factor: 2.967

7.  Transsacral colon fistula: late complication after resection, irradiation and free flap transfer of sacral chondrosarcoma.

Authors:  Lars Steinstraesser; Michael Sand; Stefan Langer; Gert Muhr; Thomas A Schildhauer; Hans-Ulrich Steinau
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

8.  Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone.

Authors:  Alexander Rabinovich; Isabella W Y Mak; Robert W Cowan; Robert E Turcotte; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Open Bone J       Date:  2009

9.  Giant cell tumour with a lipoma of the sacrum.

Authors:  E Laugharne; A Stirling; R Grimer
Journal:  J Surg Case Rep       Date:  2012-07-01

10.  Huge giant cell tumor of the sacrum: A case report.

Authors:  Li-Feng Qin; Dan Peng; Li-Hua Qin; Min Xu; Han Fang; Qing Zhang
Journal:  Oncol Lett       Date:  2014-01-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.